Artificial Implants

Artificial Implants

Global Artificial Implants Market to Reach US$112.7 Billion by 2030

The global market for Artificial Implants estimated at US$77.4 Billion in the year 2023, is expected to reach US$112.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Cardiac Implants, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$52.0 Billion by the end of the analysis period. Growth in the Spinal Implants segment is estimated at 5.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$20.9 Billion While China is Forecast to Grow at 9.4% CAGR

The Artificial Implants market in the U.S. is estimated at US$20.9 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$25.4 Billion by the year 2030 trailing a CAGR of 9.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Artificial Implants Market - Key Trends and Drivers Summarized

Artificial implants have revolutionized healthcare by offering innovative solutions for replacing or supporting damaged biological structures, delivering drugs, and enhancing sensory and motor functions. These devices, crucial in treating a wide array of medical conditions, are crafted from advanced materials designed to be biocompatible, durable, and in many cases, hypoallergenic to minimize patient discomfort and the need for subsequent surgeries. Innovations in implant technology have significantly evolved since the first pacemaker implant in 1958, with advances including responsive polymers that minimize tissue damage during insertion or removal. These improvements have expanded the functionality and applications of medical implants, which now include cardiovascular devices like stents and pacemakers, orthopedic implants such as artificial joints, neurological devices for conditions like Parkinson`s disease, and various drug delivery systems and implantable biosensors.

The development of medical implants has been particularly enhanced by the advent of materials like polyethylene, titanium, and 3-D printed biomaterials, tailored to meet specific medical needs such as joint stability or tissue compatibility. Recent innovations have focused on creating artificial bones with properties that closely mimic natural bone, enhancing integration and reducing rejection risks. This effort is exemplified by a dedicated team at the University of São Paulo, which has made significant advancements in surgical prostheses using materials like alumina and polymethyl methacrylate (PMMA), designed with porous surfaces to facilitate vascularization and bone ingrowth. These developments are particularly promising for reconstructive surgeries in the skull, jaw, and other orthopedic areas, where materials must combine structural integrity with biological compatibility. Techniques such as adding sucrose to ceramic agglomerates or carboxymethyl cellulose to PMMA to induce porosity are enhancing the biological activity of these materials, improving their integration into human tissues.

The growth of the artificial implant market is driven by several key factors. Technological advancements in material science have led to the development of implants with improved durability and integration capabilities. Regulatory changes and more favorable reimbursement policies are also significant growth drivers, encouraging the adoption of new technologies. The increasing global aging population naturally elevates the demand for implants due to prevalent age-related ailments, while consumer preferences for minimally invasive surgeries stimulate demand for advanced implantable devices. Moreover, the expansion of application areas beyond traditional fields into neurology and cosmetic surgery is broadening the market for implants. Collaborative efforts between academic institutions and the implant industry are accelerating innovation and commercialization, supported by significant public and private investment in research and development. Additionally, the trend toward personalized medical treatments, including patient-specific implants, is enhancing outcomes and satisfaction, further propelling the adoption and advancement of artificial implants in medical practice.

Select Competitors (Total 156 Featured) -

• Abiomed, Inc.
• Bicon, LLC
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cochlear Limited
• Dentsply Sirona
• DePuy Synthes Companies
• Exactech Inc.
• GS Medical LLC
• Institut Straumann AG
• Integra Lifesciences Holdings Corporation
• Japan Medical Dynamic Marketing Inc.
• Medtronic plc
• Nobel Biocare Services AG
• RTI Surgical, Inc.
• Showa Ika Kohgyo Co., Ltd
• Smith & Nephew Plc
• Sonova Holding AG
• St. Jude Medical, Inc.
• Stryker Corporation
• Terumo Corporation
• TTK Healthcare, Ltd.
• Wright Medical Group N.V.
• Zimmer Biomet Holdings, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.